Document is current
Any future updates will be listed below
-
Authors
Andrés-Camazón, Pablo https://orcid.org/0000-0002-7322-1248
Diaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Ballem, Ram
Chen, Jiayu
Calhoun, Vince D. https://orcid.org/0000-0001-9058-0747
Iraji, Armin
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01MH123610, R01MH123610)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 26 February 2025
First Online: 19 March 2025
Competing interests
: P.A.C. has received travel support from Neuraxpharm, ROVI, and Casen Recordati. C.D.C. has received honoraria or travel support from Angelini, Viatris, and Janssen. J.C., R.B., V.C., and A.I. reported no biomedical financial interests or potential conflicts of interest.
